The development of targeted therapies for complex diseases often hinges on the availability of sophisticated chemical intermediates. Within the pharmaceutical sector, Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate (CAS: 848574-60-7) has emerged as a compound of significant importance, primarily due to its essential role in the synthesis of Roflumilast. This compound, appearing as a fine white powder, is a testament to the precision required in modern chemical manufacturing.

Roflumilast, a selective phosphodiesterase-4 (PDE4) inhibitor, is a vital medication used in the management of severe Chronic Obstructive Pulmonary Disease (COPD). Its therapeutic efficacy is directly linked to the quality of the raw materials used in its production. Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate, with its molecular formula C12H14O4, serves as a key structural component in building the Roflumilast molecule. The cyclopropylmethoxy group and the substituted benzoate core are crucial for achieving the desired biological activity and pharmacokinetic profile of the final drug.

For pharmaceutical companies and researchers, securing a consistent and high-quality supply of this intermediate is critical. When you need to buy Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate, choosing the right supplier is a strategic imperative. As a leading CAS 848574-60-7 supplier, our company offers guaranteed purity of ≥98.0%, ensuring that your synthesis processes yield optimal results. We understand the demanding nature of pharmaceutical R&D and manufacturing, and our operations are geared towards meeting these exacting standards.

As a reputable chemical manufacturer in China, we provide a stable and dependable source for this crucial Roflumilast intermediate. Our commitment to quality, coupled with competitive Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate price offerings, makes us an ideal partner. We encourage potential buyers to request a quotation for their specific needs, whether for research quantities or bulk production. Leveraging our expertise in chemical synthesis ensures that you receive a product that meets all necessary specifications, facilitating your work in developing advanced therapeutic solutions.

In summary, the successful synthesis of Roflumilast and the advancement of respiratory treatments depend significantly on the availability of high-quality intermediates like Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate. We are dedicated to being your trusted partner, providing the essential chemical building blocks that drive pharmaceutical innovation forward.